IDEAS home Printed from https://ideas.repec.org/f/psa1194.html
   My authors  Follow this author

Brian Salter

Personal Details

First Name:Brian
Middle Name:
Last Name:Salter
Suffix:
RePEc Short-ID:psa1194
http://www.kcl.ac.uk/sspp/departments/politicaleconomy/people/academic/salter.aspx

Affiliation

Department of Political Economy
King's College London

London, United Kingdom
http://www.kcl.ac.uk/sspp/departments/politicaleconomy/



22 Kingsway, First Floor, London WC2B 6NR
RePEc:edi:dekcluk (more details at EDIRC)

Research output

as
Jump to: Articles

Articles

  1. Brian Salter & Yinhua Zhou & Saheli Datta, 2017. "Governing new global health-care markets: the case of stem cell treatments," New Political Economy, Taylor & Francis Journals, vol. 22(1), pages 76-91, January.
  2. Salter, Brian & Zhou, Yinhua & Datta, Saheli, 2015. "Hegemony in the marketplace of biomedical innovation: Consumer demand and stem cell science," Social Science & Medicine, Elsevier, vol. 131(C), pages 156-163.
  3. Brian Salter & Alison Harvey, 2014. "Creating problems in the governance of science: Bioethics and human/animal chimeras," Science and Public Policy, Oxford University Press, vol. 41(5), pages 685-696.
  4. Salter, Brian & Salter, Charlotte, 2013. "Bioethical ambition, political opportunity and the European governance of patenting: The case of human embryonic stem cell science," Social Science & Medicine, Elsevier, vol. 98(C), pages 286-292.
  5. Harvey, Alison & Salter, Brian, 2012. "Governing the moral economy: Animal engineering, ethics and the liberal government of science," Social Science & Medicine, Elsevier, vol. 75(1), pages 193-199.
  6. Brian Salter & Charlotte Salter, 2010. "Governing innovation in the biomedicine knowledge economy: stem cell science in the USA," Science and Public Policy, Oxford University Press, vol. 37(2), pages 87-100, March.
  7. Fenton, Laura & Salter, Brian, 2009. "Competition and compromise in negotiating the new governance of medical performance: the clinical governance and revalidation policies in the UK," Health Economics, Policy and Law, Cambridge University Press, vol. 4(3), pages 283-303, July.
  8. Brian Salter & Ren-Zong Qiu, 2009. "Bioethical governance and basic stem cell science: China and the global biomedicine economy," Science and Public Policy, Oxford University Press, vol. 36(1), pages 47-59, February.
  9. Salter, Brian, 2007. "Governing UK medical performance: A struggle for policy dominance," Health Policy, Elsevier, vol. 82(3), pages 263-275, August.
  10. Salter, Brian, 2003. "Patients and doctors: reformulating the UK health policy community?," Social Science & Medicine, Elsevier, vol. 57(5), pages 927-936, September.
  11. Lynn Frewer & Brian Salter, 2002. "Public attitudes, scientific advice and the politics of regulatory policy: The case of BSE," Science and Public Policy, Oxford University Press, vol. 29(2), pages 137-145, April.
  12. Salter, Brian, 2001. "Who rules? The new politics of medical regulation," Social Science & Medicine, Elsevier, vol. 52(6), pages 871-883, March.
  13. Brian Salter & Ted Tapper, 2000. "The Politics of Governance in Higher Education: the Case of Quality Assurance," Political Studies, Political Studies Association, vol. 48(1), pages 66-87, March.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Articles

  1. Salter, Brian & Zhou, Yinhua & Datta, Saheli, 2015. "Hegemony in the marketplace of biomedical innovation: Consumer demand and stem cell science," Social Science & Medicine, Elsevier, vol. 131(C), pages 156-163.

    Cited by:

    1. Sleeboom-Faulkner, Margaret & Chekar, Choon Key & Faulkner, Alex & Heitmeyer, Carolyn & Marouda, Marina & Rosemann, Achim & Chaisinthop, Nattaka & Chang, Hung-Chieh (Jessica) & Ely, Adrian & Kato, Mas, 2016. "Comparing national home-keeping and the regulation of translational stem cell applications: An international perspective," Social Science & Medicine, Elsevier, vol. 153(C), pages 240-249.

  2. Salter, Brian & Salter, Charlotte, 2013. "Bioethical ambition, political opportunity and the European governance of patenting: The case of human embryonic stem cell science," Social Science & Medicine, Elsevier, vol. 98(C), pages 286-292.

    Cited by:

    1. Gardner, John & Webster, Andrew, 2016. "The social management of biomedical novelty: Facilitating translation in regenerative medicine," Social Science & Medicine, Elsevier, vol. 156(C), pages 90-97.

  3. Harvey, Alison & Salter, Brian, 2012. "Governing the moral economy: Animal engineering, ethics and the liberal government of science," Social Science & Medicine, Elsevier, vol. 75(1), pages 193-199.

    Cited by:

    1. Edwards, Kyle T., 2014. "Methods of legitimation: How ethics committees decide which reasons count in public policy decision-making," Social Science & Medicine, Elsevier, vol. 113(C), pages 34-41.

  4. Brian Salter & Charlotte Salter, 2010. "Governing innovation in the biomedicine knowledge economy: stem cell science in the USA," Science and Public Policy, Oxford University Press, vol. 37(2), pages 87-100, March.

    Cited by:

    1. Brian Balmer, 2011. "Life as Surplus: Biotechnology and Capitalism in the Neoliberal Era," Journal of Cultural Economy, Taylor & Francis Journals, vol. 4(1), pages 105-108, February.

  5. Fenton, Laura & Salter, Brian, 2009. "Competition and compromise in negotiating the new governance of medical performance: the clinical governance and revalidation policies in the UK," Health Economics, Policy and Law, Cambridge University Press, vol. 4(3), pages 283-303, July.

    Cited by:

    1. Price, Tristan & Tredinnick-Rowe, John & Walshe, Kieran & Tazzyman, Abigail & Ferguson, Jane & Boyd, Alan & Archer, Julian & Bryce, Marie, 2020. "Reviving clinical governance? A qualitative study of the impact of professional regulatory reform on clinical governance in healthcare organisations in England," Health Policy, Elsevier, vol. 124(4), pages 446-453.

  6. Brian Salter & Ren-Zong Qiu, 2009. "Bioethical governance and basic stem cell science: China and the global biomedicine economy," Science and Public Policy, Oxford University Press, vol. 36(1), pages 47-59, February.

    Cited by:

    1. Sleeboom-Faulkner, Margaret & Chekar, Choon Key & Faulkner, Alex & Heitmeyer, Carolyn & Marouda, Marina & Rosemann, Achim & Chaisinthop, Nattaka & Chang, Hung-Chieh (Jessica) & Ely, Adrian & Kato, Mas, 2016. "Comparing national home-keeping and the regulation of translational stem cell applications: An international perspective," Social Science & Medicine, Elsevier, vol. 153(C), pages 240-249.

  7. Salter, Brian, 2007. "Governing UK medical performance: A struggle for policy dominance," Health Policy, Elsevier, vol. 82(3), pages 263-275, August.

    Cited by:

    1. Levi, Baruch & Zehavi, Amos & Chinitz, David, 2018. "Taking the measure of the profession: Physician associations in the measurement age," Health Policy, Elsevier, vol. 122(7), pages 746-754.
    2. John Martyn Chamberlain, 2010. "Portfolio-Based Performance Appraisal for Doctors: A Case of Paperwork Compliance," Sociological Research Online, , vol. 15(1), pages 68-76, February.
    3. Price, Tristan & Tredinnick-Rowe, John & Walshe, Kieran & Tazzyman, Abigail & Ferguson, Jane & Boyd, Alan & Archer, Julian & Bryce, Marie, 2020. "Reviving clinical governance? A qualitative study of the impact of professional regulatory reform on clinical governance in healthcare organisations in England," Health Policy, Elsevier, vol. 124(4), pages 446-453.
    4. Spendlove, Zoey, 2018. "Medical revalidation as professional regulatory reform: Challenging the power of enforceable trust in the United Kingdom," Social Science & Medicine, Elsevier, vol. 205(C), pages 64-71.
    5. Bryce, Marie & Luscombe, Kayleigh & Boyd, Alan & Tazzyman, Abigail & Tredinnick-Rowe, John & Walshe, Kieran & Archer, Julian, 2018. "Policing the profession? Regulatory reform, restratification and the emergence of Responsible Officers as a new locus of power in UK medicine," Social Science & Medicine, Elsevier, vol. 213(C), pages 98-105.

  8. Salter, Brian, 2003. "Patients and doctors: reformulating the UK health policy community?," Social Science & Medicine, Elsevier, vol. 57(5), pages 927-936, September.

    Cited by:

    1. Baggott, Rob & Jones, Kathryn, 2014. "The voluntary sector and health policy: The role of national level health consumer and patients' organisations in the UK," Social Science & Medicine, Elsevier, vol. 123(C), pages 202-209.
    2. Noerreslet, Mikkel & Larsen, Jakob B. & Traulsen, Janine M., 2005. "The medicine user--Lost in translation?: Analysis of the official political debate prior to the deregulation of the Danish medicine distribution system," Social Science & Medicine, Elsevier, vol. 61(8), pages 1733-1740, October.
    3. Jones, Lorelei & Exworthy, Mark, 2015. "Framing in policy processes: A case study from hospital planning in the National Health Service in England," Social Science & Medicine, Elsevier, vol. 124(C), pages 196-204.
    4. Salter, Brian & Zhou, Yinhua & Datta, Saheli, 2015. "Hegemony in the marketplace of biomedical innovation: Consumer demand and stem cell science," Social Science & Medicine, Elsevier, vol. 131(C), pages 156-163.
    5. Lopes, Edilene & Carter, Drew & Street, Jackie, 2015. "Power relations and contrasting conceptions of evidence in patient-involvement processes used to inform health funding decisions in Australia," Social Science & Medicine, Elsevier, vol. 135(C), pages 84-91.

  9. Lynn Frewer & Brian Salter, 2002. "Public attitudes, scientific advice and the politics of regulatory policy: The case of BSE," Science and Public Policy, Oxford University Press, vol. 29(2), pages 137-145, April.

    Cited by:

    1. Janneke De Jonge & Hans Van Trijp & Reint Jan Renes & Lynn J. Frewer, 2010. "Consumer Confidence in the Safety of Food and Newspaper Coverage of Food Safety Issues: A Longitudinal Perspective," Risk Analysis, John Wiley & Sons, vol. 30(1), pages 125-142, January.
    2. Lynn J. Frewer & Joachim Scholderer & Lone Bredahl, 2003. "Communicating about the Risks and Benefits of Genetically Modified Foods: The Mediating Role of Trust," Risk Analysis, John Wiley & Sons, vol. 23(6), pages 1117-1133, December.
    3. Youtie, Jan & Bozeman, Barry & Jabbehdari, Sahra & Kao, Andrew, 2017. "Credibility and use of scientific and technical information in policy making: An analysis of the information bases of the National Research Council’s committee reports," Research Policy, Elsevier, vol. 46(1), pages 108-120.
    4. Houghton, J.R. & Rowe, G. & Frewer, L.J. & Van Kleef, E. & Chryssochoidis, G. & Kehagia, O. & Korzen-Bohr, S. & Lassen, J. & Pfenning, U. & Strada, A., 2008. "The quality of food risk management in Europe: Perspectives and priorities," Food Policy, Elsevier, vol. 33(1), pages 13-26, February.
    5. E B Ryan & D Fraser & D M Weary, 2015. "Public Attitudes to Housing Systems for Pregnant Pigs," PLOS ONE, Public Library of Science, vol. 10(11), pages 1-14, November.
    6. Rothstein, Henry, 2003. "Precautionary bans or sacrificial lambs? Participative risk regulation and the reform of the UK food safety regime," LSE Research Online Documents on Economics 36002, London School of Economics and Political Science, LSE Library.
    7. E. Van Kleef & J. R. Houghton & A. Krystallis & U. Pfenning & G. Rowe & H. Van Dijk & I. A. Van der Lans & L. J. Frewer, 2007. "Consumer Evaluations of Food Risk Management Quality in Europe," Risk Analysis, John Wiley & Sons, vol. 27(6), pages 1565-1580, December.
    8. Krapohl, Sebastian & Zurek, Karolina, 2006. "The Perils of Committee Governance: Intergovernmental Bargaining during the BSE Scandal in the European Union," European Integration online Papers (EIoP), European Community Studies Association Austria (ECSA-A), vol. 10, May.

  10. Salter, Brian, 2001. "Who rules? The new politics of medical regulation," Social Science & Medicine, Elsevier, vol. 52(6), pages 871-883, March.

    Cited by:

    1. Anja Shortland & Andrew Shortland, 2020. "Governance under the shadow of the law: trading high value fine art," Public Choice, Springer, vol. 184(1), pages 157-174, July.
    2. Bryce, Marie & Luscombe, Kayleigh & Boyd, Alan & Tazzyman, Abigail & Tredinnick-Rowe, John & Walshe, Kieran & Archer, Julian, 2018. "Policing the profession? Regulatory reform, restratification and the emergence of Responsible Officers as a new locus of power in UK medicine," Social Science & Medicine, Elsevier, vol. 213(C), pages 98-105.

  11. Brian Salter & Ted Tapper, 2000. "The Politics of Governance in Higher Education: the Case of Quality Assurance," Political Studies, Political Studies Association, vol. 48(1), pages 66-87, March.

    Cited by:

    1. Rivera, Jaime & Alarcón, Víctor, 2020. "Model for assessing the quality of marketing-management education," Journal of Economics, Finance and Administrative Science, Universidad ESAN, vol. 25(49), pages 5-25.
    2. Russell Craig & Joel Amernic, 2002. "Accountability of accounting educators and the rhythm of the university: resistance strategies for postmodern blues," Accounting Education, Taylor & Francis Journals, vol. 11(2), pages 121-171.
    3. Shin, Jung Cheol, 2018. "Quality assurance systems as a higher education policy tool in Korea: International convergence and local contexts," International Journal of Educational Development, Elsevier, vol. 63(C), pages 52-58.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Brian Salter should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.